Publications by authors named "Jason Gordon"

Claim this Profile
A
Antimicrobial resistance trends, predictors, and burden in England: a retrospective study using the Clinical Practice Research Datalink from 2015 to 2021.
Amer Taie, Maria Gheorghe, James Amos, Alec Morton, Jason Gordon

Int J Antimicrob Agents· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The legacy effect of early HbA1c control on microvascular complications and hospital admissions in type 2 diabetes: findings from a large UK study.
Rami Aldafas, Yana Vinogradova, Thomas S J Crabtree, Jason Gordon, Iskandar Idris

Ther Adv Endocrinol Metab· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accessibility of Childcare Services for Children With Disabilities Aged 0 to 5 Years: A Scoping Review of Promising Solutions.
François Routhier, Josiane Lettre, Maude Lemieux, Fidélia Longchamps, Gbetogo Maxime Kiki, Jason Gordon

Child Care Health Dev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Nivolumab Plus Ipilimumab versus Chemotherapy for Previously Untreated Metastatic NSCLC Using Mixture-Cure Survival Analysis Based on CheckMate 227 5-Year Data.
Alison D Griffiths, Robert O Young, Yong Yuan, Mohammad A Chaudhary, Adam Lee, Jason Gordon

Pharmacoecon Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the value of new antibiotic treatment strategies in Zhejiang province, China: cost-effectiveness analysis based on a validated dynamic model.
Wenqianzi Yang, Xuemei Zhen, Xueshan Sun, Shikha Upadhyaya Khatiwada, Danhong Yang, Jason Gordon

BMJ Open· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the Treatment and Prophylactic Economic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the USA: A Population Modelling Study.
Jason Gordon, Maria Gheorghe, Cale Harrison, Ryan Miller, James Dennis

Pharmacoeconomics· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchers.
Kevin G Pollock, Carissa Dickerson, Manjit Kainth, Sarah Lawton, Michael Hurst, Jason Gordon

BMC Prim Care· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capturing Value Attributes in the Economic Evaluation of Ceftazidime with Avibactam for Treating Severe Aerobic Gram-Negative Bacterial Infections in the United Kingdom.
Jason Gordon, Maria Gheorghe, Simon Goldenberg, Ryan Miller, James Dennis

Pharmacoeconomics· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan.
Motoyuki Sugai, Akira Yuasa, Ryan L Miller, Vasileios Vasilopoulos, Hitomi Kurosu, Jason P Gordon

Infect Dis Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the Economic and Clinical Value of Reducing Antimicrobial Resistance in Gram-negative Pathogens Causing Hospital-Acquired Infections in Australia.
Jason P Gordon, Amer Al Taie, Ryan L Miller, James W Dennis, Mark A T Blaskovich

Infect Dis Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Economic Value of Reducing Antimicrobial Resistance in the Management of Hospital-Acquired Infections with Limited Treatment Options in Greece.
Myrto Barmpouni, Jason P Gordon, Ryan L Miller, James W Dennis, Vassilis Grammelis

Infect Dis Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan.
Motoyuki Sugai, Akira Yuasa, Ryan L Miller, Vasileios Vasilopoulos, Hitomi Kurosu, Jason P Gordon

Infect Dis Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcome measures and patient engagement in heart failure clinical trials: multi-stakeholder perspectives.
Faiez Zannad, Jacqueline Alikhaani, Sadegh Alikhaani, Javed Butler, Jason Gordon

Eur J Heart Fail· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the Clinical and Economic Impact of Introducing a New Antibacterial into Greek Clinical Practice for the Management of Hospital-Acquired Infections with Limited Treatment Options.
Myrto Barmpouni, Jason P Gordon, Ryan L Miller, Clive R J Pritchard, James W Dennis

Infect Dis Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the Economic and Clinical Value of Introducing Ceftazidime/Avibactam into Antimicrobial Practice in Japan: A Dynamic Modelling Study.
Tetsuya Matsumoto, Akira Yuasa, Ryan Miller, Clive Pritchard, Takahisa Ohashi, Jason Gordon

Pharmacoecon Open· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of intensive versus conventional glucose targets in people with type 2 diabetes: a systematic review and meta-analysis.
Rami Aldafas, Thomas Crabtree, Yana Vinogradova, Jason P Gordon, Iskandar Idris

Expert Rev Endocrinol Metab· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in England.
Nathan R Hill, Lara Groves, Carissa Dickerson, Rebecca Boyce, Sarah Lawton, Jason Gordon

J Med Econ· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of undiagnosed atrial fibrillation using a machine learning risk-prediction algorithm and diagnostic testing (PULsE-AI) in primary care: a multi-centre randomized controlled trial in England.
Nathan R Hill, Lara Groves, Carissa Dickerson, Andreas Ochs, Dong Pang, Jason Gordon

Eur Heart J Digit Health· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive glycemic control and macrovascular, microvascular, hypoglycemia complications and mortality in older (age ≥60years) or frail adults with type 2 diabetes: a systematic review and meta-analysis from randomized controlled trial and observation studies.
Thomas Crabtree, Jael-Joy Ogendo, Yana Vinogradova, Jason Gordon, Iskandar Idris

Expert Rev Endocrinol Metab· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making.
Jason Gordon, Angela Stainthorpe, Beverley Jones, Ian Jacob, Nadine Hertel

Pharmacoecon Open· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical cost evaluation and health benefits of post-bariatric intervention for patients with type 2 diabetes living in the UK.
Mohammed Alkharaiji, Uchenna Anyanwagu, Thomas Crabtree, Jason Gordon, Iskandar Idris

Clin Obes· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial dependence and determinants of conservation easement adoptions in the United States.
Sabhyata Lamichhane, Changyou Sun, Jason S Gordon, Stephen C Grado, Krishna P Poudel

J Environ Manage· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan.
Tetsuya Matsumoto, Oliver Darlington, Ryan Miller, Jason Gordon, Phil McEwan

J Health Econ Outcomes Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting undiagnosed atrial fibrillation in UK primary care: Validation of a machine learning prediction algorithm in a retrospective cohort study.
Sara Sekelj, Belinda Sandler, Ellie Johnston, Kevin G Pollock, Nathan R Hill, Jason Gordon

Eur J Prev Cardiol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of undiagnosed atrial fibrillation patients using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI): Study protocol for a randomised controlled trial.
Nathan R Hill, Chris Arden, Lee Beresford-Hulme, A John Camm, David Clifton, Jason Gordon

Contemp Clin Trials· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis